Sensible Biotechnologies

Developer of mRNA technology for therapeutics and vaccines

placeWilmington, Delaware, United States calendar_todayFounded 2021 groups12 employees language sensible.bio

Registered entities

Innovation

2 patent families — focus: Chemistry & metallurgy; filing pace active. Cited 3 times.

YearFilings
20251
20261

Social engagement

Social engagement: 3.4K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Y Combinator, BlueYard.

Investor typeCountShare
Venture capital675%
Other / undisclosed225%

Recent activity

19 Jun 2026
Event
RNA Leaders APAC 2026
7 Jun 2026
Event
bio:cap 2026 – Life Science & AI Investival
11 May 2026
Event
TIDES 2026
Coming soon